PROJECTS & COLLABORATIONS
SciAnalytical is the partner of choice to numerous pharmaceutical, biotechnology and clinical diagnostics companies. Services span drug discovery and development, including methods for absorption screening, biomarker discovery, target engagement and clinical assay method development, including methods for opiates, drugs of abuse, cannabinoids, barbiturates, therapeutic drug monitoring (immunosuppressants).
To set the industry standard for CRO-Client relations. We strive to be the most responsive, resourceful, collaborative, insightful and cost competitive team of analytical scientists supporting those companies lacking the internal analytical infrastructure and mass spectrometry resources. Our commitment is to deliver the highest quality data to help drive programs from the early discovery phase into the clinic.
Our mission is to provide "best-in-class" and "first-in-class" analytical chemistry, bioanalytical chemistry and biomarker discovery services to biotechnology, pharmaceutical and clinical industries. We are the partner of choice to pharma and biotech companies that do not have their own analytical infrastructure, serving ostensibly as their analytical/DMPK department. We are also ideal partners for larger organizations who are seeking the highest quality, flexibility and industry-leading turn-around times!
We have been collaborating with SciAnalytical Strategies for over 2 years and are thrilled with the support. They are not only a service provider to our organization, but more importantly, a true partner to us, as they have been key in developing our analytical strategy, functioning ostensibly as our remote site analytical sciences department.
Carl Kaub, E-Molecules, Director of Operations